Back to Search
Start Over
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
- Source :
- Lancet Oncology, 17(11), E510-E514. Lancet Publishing Group, The Lancet Oncology, 17(11), E510-E514, Bottomley, A, Pe, M, Sloan, J, Basch, E, Bonnetain, F, Calvert, M, Campbell, A, Cleeland, C, Cocks, K, Collette, L, Dueck, A C, Devlin, N, Flechtner, H-H, Gotay, C, Greimel, E, Griebsch, I, Groenvold, M, Hamel, J-F, King, M, Kluetz, P G, Koller, M, Malone, D C, Martinelli, F, Mitchell, S A, Moinpour, C M, Musoro, J, O'Connor, D, Oliver, K, Piault-Louis, E, Piccart, M, Pimentel, F L, Quinten, C, Reijneveld, J C, Schürmann, C, Smith, A W, Soltys, K M, Taphoorn, M J B, Velikova, G, Coens, C & Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) consortium 2016, ' Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials : a start in setting international standards ', Lancet Oncology, vol. 17, no. 11, pp. E510-E514 . https://doi.org/10.1016/S1470-2045(16)30510-1
- Publication Year :
- 2016
-
Abstract
- Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data in cancer randomised trials to assist in assessing the risks and benefits of cancer therapies and fostering patient-centred cancer care. However, the various ways these measures are analysed and interpreted make it difficult to compare results across trials, and hinders the application of research findings to inform publications, product labelling, clinical guidelines, and health policy. To address these problems, the Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) initiative has been established. This consortium, directed by the European Organisation for Research and Treatment of Cancer (EORTC), was convened to provide recommendations on how to standardise the analysis of HRQOL and other patient-reported outcomes data in cancer randomised trials. This Personal View discusses the reasons why this project was initiated, the rationale for the planned work, and the expected benefits to cancer research, patient and provider decision making, care delivery, and policy making.
- Subjects :
- medicine.medical_specialty
Clinical Trials as Topic
business.industry
Cancer clinical trial
Alternative medicine
MEDLINE
Cancer
medicine.disease
03 medical and health sciences
0302 clinical medicine
Quality of life (healthcare)
Oncology
030220 oncology & carcinogenesis
Family medicine
Neoplasms
medicine
Quality of Life
Humans
Patient-reported outcome
030212 general & internal medicine
Risks and benefits
Patient Reported Outcome Measures
business
Health policy
Subjects
Details
- Language :
- English
- ISSN :
- 14702045
- Database :
- OpenAIRE
- Journal :
- Lancet Oncology, 17(11), E510-E514. Lancet Publishing Group, The Lancet Oncology, 17(11), E510-E514, Bottomley, A, Pe, M, Sloan, J, Basch, E, Bonnetain, F, Calvert, M, Campbell, A, Cleeland, C, Cocks, K, Collette, L, Dueck, A C, Devlin, N, Flechtner, H-H, Gotay, C, Greimel, E, Griebsch, I, Groenvold, M, Hamel, J-F, King, M, Kluetz, P G, Koller, M, Malone, D C, Martinelli, F, Mitchell, S A, Moinpour, C M, Musoro, J, O'Connor, D, Oliver, K, Piault-Louis, E, Piccart, M, Pimentel, F L, Quinten, C, Reijneveld, J C, Schürmann, C, Smith, A W, Soltys, K M, Taphoorn, M J B, Velikova, G, Coens, C & Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) consortium 2016, ' Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials : a start in setting international standards ', Lancet Oncology, vol. 17, no. 11, pp. E510-E514 . https://doi.org/10.1016/S1470-2045(16)30510-1
- Accession number :
- edsair.doi.dedup.....79dda2b58967c2b2dfb04a6e26c4219d
- Full Text :
- https://doi.org/10.1016/S1470-2045(16)30510-1